People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sorbent Therapeutics Inc | — | Pharmaceuticals | Series B | $58.6M | $221.0M | 2011 |
| Zikani Therapeutics, Inc. | — | Pharmaceuticals | Series A | $31.7M | $232.3M | 2018 |
| Trellis Bioscience Inc | — | Biotechnology | Series A | $23.4M | $8.5M | 2009 |
| Merganser Biotech, Inc. | — | Biotechnology | Series A | $21.1M | $473.5M | 2015 |
Markus Goebel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Markus Goebel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Somu Subramaniam | 1 | 17 |
| James Topper | 1 | 12 |
| John Friedman | 1 | 9 |
| Lawrence Miller | 1 | 8 |
| James Healy | 1 | 8 |
| David Collier | 1 | 8 |
| James I. Healy | 1 | 7 |
| Scott Minick | 1 | 7 |
| Joseph Zakrzewski | 1 | 6 |
| Jeffrey Bird | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Raj Parekh | 1 | 5 |
| Vikas Goyal | 1 | 5 |
| Henry Skinner | 1 | 4 |
| Andrew Myers | 1 | 4 |
| Brian MacDonald | 1 | 4 |
| Gerald McMahon | 1 | 3 |
| Mary Szela | 1 | 3 |
| Linda Ara | 1 | 3 |
| Randall Woods | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.